Literature DB >> 23598199

Effects of ionic liquid and nanogold particles on high-performance liquid chromatography-electrochemical detection and their application in highly efficient separation and sensitive analysis of five phenolic acids in Xuebijing injection.

Pu Jia1, Shixiang Wang, Xue Meng, Wei Lan, Jing Luo, Sha Liao, Chaoni Xiao, Xiaopu Zheng, Lianshe Li, Qinshe Liu, Jianbin Zheng, Yuanzhen Zhou, Xiaohui Zheng.   

Abstract

A novel high performance liquid chromatography-electrochemical detector (HPLC-ECD) analytical system was developed in this study by integratedly utilizing ionic liquid (IL) of 1-butyl-3-methylimidazolium bromide and an additive of gold nanoparticles. The resulted pilot study was first performed to assess the effects of 1-butyl-3-methylimidazolium bromide and gold nanoparticles on the chromatographic characteristics of five phenolic acids in Xuebijing injection, including danshensu (DSS), protocatechuic acid (PA), protocatechuic aldehyde (PAH), hydroxy safflower yellow A (HSYA) and ferulic acid (FA). It was notable to observe that retainability of the phenolic acids were markly lowered by IL addition. Compared with the cases without IL addition, the retention times of DSS, PA, PAH, HSYA and FA have decreased 2.851, 1.532, 1.53, 0.818 and 0.552 min, respectively when 0.6% IL in the mobile phase. In addition, the corresponding theoretical plate numbers and peak areas for these compounds were significantly increased. Area response for DSS, PA, PAH, HSYA and FA were enhanced by 772%, 628%, 584%, 703% and 600%, respectively. It was observed that nano-gold catalysis power enabled peak areas of DSS, PAH, FA and PA to enhance 5.7, 6.2, 8.5 and 66.5 times relative to the case with addition of IL. Altogether, the optimized HPLC-ECD system was successfully applied to the pharmacokinetics study of Xuebijing injection with underlying applicability to in vivo and in vitro analysis of a variety of natural product from Chinese medicine plants, TCM formulae and associated patent TCM preparation.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23598199     DOI: 10.1016/j.talanta.2012.12.031

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  9 in total

Review 1.  Pharmacological Activities of Safflower Yellow and Its Clinical Applications.

Authors:  Yan Chen; Meifeng Li; Jiayu Wen; Xiaoqi Pan; Zixin Deng; Junren Chen; Guanru Chen; Lei Yu; Yunli Tang; Gangmin Li; Xiaofang Xie; Cheng Peng
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-27       Impact factor: 2.650

2.  A Case-Control Study of Continuous Veno-Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis.

Authors:  Yan Liu; Bing Wang; Qian Zhang; Yuliang Zhao; Xudong Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-05-28       Impact factor: 3.009

3.  Xuebijing injection for acute organophosphorus pesticide poisoning: a systematic review and meta-analysis.

Authors:  Po Huang; Bo Li; Shuo Feng; Yuhong Guo; Guozhen Zhao; Dongdong Wang; Qingquan Liu
Journal:  Ann Transl Med       Date:  2019-03

4.  Traditional chinese medicine Xuebijing treatment is associated with decreased mortality risk of patients with moderate paraquat poisoning.

Authors:  Ping Gong; Zhidan Lu; Jing Xing; Na Wang; Yu Zhang
Journal:  PLoS One       Date:  2015-04-29       Impact factor: 3.240

5.  Chemical profiling and quantification of XueBiJing injection, a systematic quality control strategy using UHPLC-Q Exactive hybrid quadrupole-orbitrap high-resolution mass spectrometry.

Authors:  Zhi Sun; Lihua Zuo; Tongwen Sun; Jinfa Tang; Daling Ding; Lin Zhou; Jian Kang; Xiaojian Zhang
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

6.  Treatment effects of xuebijing injection in severe septic patients with disseminated intravascular coagulation.

Authors:  Qin Yin; Chunsheng Li
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-23       Impact factor: 2.629

7.  Protective effect of Xuebijing injection on D-galactosamine- and lipopolysaccharide-induced acute liver injury in rats through the regulation of p38 MAPK, MMP-9 and HO-1 expression by increasing TIPE2 expression.

Authors:  Ming-Wei Liu; Rong Liu; Hai-Yin Wu; Wei Zhang; Jing Xia; Min-Na Dong; Wen Yu; Qiang Wang; Feng-Mei Xie; Rui Wang; Yun-Qiao Huang; Chuan-Yun Qian
Journal:  Int J Mol Med       Date:  2016-09-23       Impact factor: 4.101

8.  Amelioration of paraquat-induced pulmonary fibrosis in mice by regulating miR-140-5p expression with the fibrogenic inhibitor Xuebijing.

Authors:  Min-Na Dong; Yun Xiao; Yun-Fei Li; Dong-Mei Wang; Ya-Ping Qu; Tian-Wen Fang; Hui Li; Ming-Wei Liu
Journal:  Int J Immunopathol Pharmacol       Date:  2020 Jan-Dec       Impact factor: 3.219

9.  Pharmacokinetics of Active Ingredients of Salvia miltiorrhiza and Carthamus tinctorius in Compatibility in Normal and Cerebral Ischemia Rats: A Comparative Study.

Authors:  Ying Jin; Li Yu; Fangfang Xu; Jie Zhou; Bing Xiong; Yinshan Tang; Xiaohong Li; Lanying Liu; Weifeng Jin
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2020-04       Impact factor: 2.441

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.